Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, everyone, and welcome to the A2 Biopharma Fiscal 2025 Q2 Earnings Call. At this time, all participants have been placed on a listen-only mode. If you have any questions or comments during the presentation, you may press star 1 on your phone to enter the question queue at any time, and we will open the floor for your questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Robert Bloom. Sir, the floor is yours. All right, thank you very much and good afternoon everyone, as the operator indicated during today's call we will be discussing a to bio pharma fiscal 2025 second quarter operational and financial results for the period ended December 31 2024. Joining us on today's call is a to chief executive officer josh disbro and Ryan sell horn the company's chief financial officer. At the conclusion of today's prepared remarks, we will open the call for a question and answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the teleconference numbers and conference ID provided in the press release issued earlier today or by utilizing the link on the company's website under events and presentations. Finally, I'd also like to call to your attention the customary safe harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements, including statements regarding the goals, strategies, beliefs, expectations, and future potential operating results of A2 Biopharma. Although management believes these statements are reasonable based on estimates, assumptions, and projections as of today, these statements are not guaranteed a future performance. Time-sensitive information may no long...